Chiudi menu
Group
Companies
History
Mission, Vision and Values
Business model
Innovation
Scientific research
Quality and certifications
Investor Relations
Share Capital and Shareholding
Stock performance
Stock Market Research and Studies
Brokers and SDIR
Financial statements and reports
Company profile
Presentations
Corporate Events
Euronext Milan Prospectus
Governance
Code of ethics and policies
Model 231
Whistleblowing Reports
BOD and Committees
Statutory auditors and Audit firm
Shareholders’ Meeting
Company Documents
Internal Dealing
Sharholders Agreements
Sustainability
ESG PLAN AND SUSTAINABILITY REPORTS
SOCIAL COMMITMENT
Company Welfare
Our commitment to Sport
Careers
Media
Press releases
Press reviews
News
Chiudi ricerca
it
en
Group
Companies
History
Mission, Vision and Values
Business model
Innovation
Scientific research
Quality and certifications
Investor Relations
Share Capital and Shareholding
Stock performance
Stock Market Research and Studies
Brokers and SDIR
Financial statements and reports
Company profile
Presentations
Corporate Events
Euronext Milan Prospectus
Governance
Code of ethics and policies
Model 231
Whistleblowing Reports
BOD and Committees
Statutory auditors and Audit firm
Shareholders’ Meeting
Company Documents
Internal Dealing
Sharholders Agreements
Sustainability
ESG PLAN AND SUSTAINABILITY REPORTS
SOCIAL COMMITMENT
Company Welfare
Our commitment to Sport
Careers
Media
Press releases
Press reviews
News
News
INITIATION OF SHARE BUY-BACK PROGRAM
BOARD OF DIRECTORS APPROVES THE HALF-YEAR FINANCIAL REPORT AS OF 30 JUNE 2025
Pharmanutra at GOAL! Festival 2025: ethics, health and sports culture
GREAT MARKET RESPONSE FOR SIDEVIT® B12 JUST SIX MONTHS AFTER ITS LAUNCH IN ITALY
Pharmanutra renews sponsorship with Pisa Sporting Club
PharmaNutra launches its official store on Amazon
PHARMANUTRA LAUNCHES THE NEW NUTRITIONAL SUPPLEMENT APPORTAL® BOOST
THE BOARD OF DIRECTORS APPROVES THE INTERIM MANAGEMENT REPORT AS AT MARCH 31, 2025
Allegato 3F – Aprile 2025
PHARMANUTRA S.P.A.: PARTNERSHIP WITH GIRO D’ITALIA
SHAREHOLDERS’ MEETING OF 16/04/2025 – REPORT OF VOTING RESULTS
ORDINARY AND EXTRAORDINARY SHAREHOLDERS’ MEETING OF 16 APRIL 2025
THE INTERNATIONALISATION PROCESS CONTINUES
Allegato 3F – Marzo 2025
NEWS AND UPDATES ON FOREIGN MARKETS
FILING OF DOCUMENTS FOR THE SHAREHOLDERS’ MEETING
ANOTHER YEAR WITH FERNANDO ALONSO
SUCROSOMIAL IRON® MENTIONED IN THE GUIDELINES OF THE WORLD HEALTH ORGANISATION
RENEWED THE PARTNERSHIP WITH AF CORSE
PHARMANUTRA S.P.A. TO ATTEND THE EURONEXT STAR CONFERENCE 2025
Loading...
